CEREBEL_2B: CEREBEL, figure 2B

CEREBEL_2BR Documentation

CEREBEL, figure 2B

Description

Kaplan-Meier digitized data from CEREBEL, figure 2B (PMID 25605838). A reported sample size of 540 for a primary endpoint of Incidence_CNSmets in breast cancer.

Usage

CEREBEL_2B

Format

A data frame of 540 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (lapatinib_cape, trastuzumab_cape)

Source

Pivot X, Manikhas A, Żurawski B, et al. CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. J Clin Oncol 2015; 33: 1564–73.

Examples

summary(CEREBEL_2B)

kmplot(CEREBEL_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.